Hipulan, Jimber L.

HRN: 26-44-96  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/24/2026
CEFUROXIME 750MG (VIAL)
02/24/2026
03/10/2026
IV
300mg
Q8
PCAP-C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: